Summit Market Cap from 2010 to 2024

SMMT Stock  USD 18.67  0.80  4.48%   
Summit Therapeutics Market Cap yearly trend continues to be comparatively stable with very little volatility. Market Cap is likely to outpace its year average in 2024. From the period from 2010 to 2024, Summit Therapeutics Market Cap quarterly data regression had r-value of  0.52 and coefficient of variation of  99.99. View All Fundamentals
 
Market Cap  
First Reported
2010-12-31
Previous Quarter
1.6 B
Current Value
1.7 B
Quarterly Volatility
544.7 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Summit Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Summit Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 95.3 M, Interest Expense of 17.3 M or Selling General Administrative of 31.8 M, as well as many indicators such as Price To Sales Ratio of 1.3 K, Dividend Yield of 0.0 or PTB Ratio of 19.78. Summit financial statements analysis is a perfect complement when working with Summit Therapeutics Valuation or Volatility modules.
  
Check out the analysis of Summit Therapeutics Correlation against competitors.

Latest Summit Therapeutics' Market Cap Growth Pattern

Below is the plot of the Market Cap of Summit Therapeutics PLC over the last few years. It is Summit Therapeutics' Market Cap historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Summit Therapeutics' overall financial position and show how it may be relating to other accounts over time.
Market Cap10 Years Trend
Slightly volatile
   Market Cap   
       Timeline  

Summit Market Cap Regression Statistics

Arithmetic Mean544,793,199
Geometric Mean320,322,515
Coefficient Of Variation99.99
Mean Deviation425,561,653
Median326,763,496
Standard Deviation544,737,971
Sample Variance296739.5T
Range1.7B
R-Value0.52
Mean Square Error232381.1T
R-Squared0.27
Significance0.05
Slope63,622,724
Total Sum of Squares4154352.4T

Summit Market Cap History

20241.7 B
20231.6 B
2022821.7 M
2021248.1 M
2020326.8 M
2019198 M
201887.4 M

About Summit Therapeutics Financial Statements

Summit Therapeutics shareholders use historical fundamental indicators, such as Market Cap, to determine how well the company is positioned to perform in the future. Although Summit Therapeutics investors may analyze each financial statement separately, they are all interrelated. The changes in Summit Therapeutics' assets and liabilities, for example, are also reflected in the revenues and expenses on on Summit Therapeutics' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Market Cap1.6 B1.7 B

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Summit Stock Analysis

When running Summit Therapeutics' price analysis, check to measure Summit Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Summit Therapeutics is operating at the current time. Most of Summit Therapeutics' value examination focuses on studying past and present price action to predict the probability of Summit Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Summit Therapeutics' price. Additionally, you may evaluate how the addition of Summit Therapeutics to your portfolios can decrease your overall portfolio volatility.